Page last updated: 2024-09-05

organophosphonates and Arteriosclerosis

organophosphonates has been researched along with Arteriosclerosis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eller, P; Patsch, JR; Ritsch, A; Tancevski, I	1
Dominguez, Z; Dubois, M; Lagarde, M; Macovschi, O; Merhi-Soussi, F; Prigent, AF; Savany, A	1
Bruggeman, CA; Bruning, JH; De Clercq, E; Lemström, K; Persoons, M; Stals, FS	1
Caniggia, A; Gennari, C; Picchi, M	1

Reviews

1 review(s) available for organophosphonates and Arteriosclerosis

Article	Year
The resurgence of thyromimetics as lipid-modifying agents. Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:9 Topics: Acetates; Anilides; Animals; Anticholesteremic Agents; Arteriosclerosis; Atherosclerosis; Biological Transport; Biomimetics; Cholesterol, LDL; Clinical Trials as Topic; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Malonates; Molecular Structure; Organophosphonates; Phenols; Phenyl Ethers; Phenylacetates; Propionates; Pyridazines; Receptors, LDL; Thyroid Gland; Thyroid Hormones	2009

Article

Year

The resurgence of thyromimetics as lipid-modifying agents.

Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:9

Topics: Acetates; Anilides; Animals; Anticholesteremic Agents; Arteriosclerosis; Atherosclerosis; Biological Transport; Biomimetics; Cholesterol, LDL; Clinical Trials as Topic; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Malonates; Molecular Structure; Organophosphonates; Phenols; Phenyl Ethers; Phenylacetates; Propionates; Pyridazines; Receptors, LDL; Thyroid Gland; Thyroid Hormones

2009

Other Studies

3 other study(ies) available for organophosphonates and Arteriosclerosis

Article	Year
Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA2. Journal of leukocyte biology, 2000, Volume: 68, Issue:6 Topics: Adult; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Calcium; Cell Adhesion; Cells, Cultured; Chelating Agents; Coculture Techniques; Culture Media, Conditioned; Cyclooxygenase 1; Cyclooxygenase 2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Egtazic Acid; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Gene Expression Regulation; Group IV Phospholipases A2; Humans; Infant, Newborn; Intramolecular Oxidoreductases; Isoenzymes; Lipopolysaccharides; Lymphocytes; Membrane Proteins; Organophosphonates; Phospholipases A; Phospholipases A2; Prostaglandin H2; Prostaglandin-Endoperoxide Synthases; Prostaglandins H; Tranylcypromine; Umbilical Veins	2000
Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Transplant international : official journal of the European Society for Organ Transplantation, 1994, Volume: 7 Suppl 1 Topics: Animals; Antiviral Agents; Aorta; Arteriosclerosis; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Graft Rejection; Male; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic; Tunica Intima; Tunica Media; Virus Replication	1994
[Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans]. Bollettino della Societa italiana di biologia sperimentale, 1974, Sep-15, Volume: 50, Issue:17 Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Etidronic Acid; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Organophosphonates; Organophosphorus Compounds	1974